Free Trial

Abingdon Health (ABDX) Competitors

Abingdon Health logo
GBX 5.64 +0.14 (+2.52%)
As of 12:28 PM Eastern

ABDX vs. AGL, YGEN, PRM, VRCI, GDR, GENI, DMTR, LLAI, LLA, and IDHC

Should you be buying Abingdon Health stock or one of its competitors? The main competitors of Abingdon Health include ANGLE (AGL), Yourgene Health (YGEN), Proteome Sciences (PRM), Verici Dx (VRCI), genedrive (GDR), GENinCode (GENI), Deepmatter Group (DMTR), LungLife AI (LLAI), LLA.L,0P0001T9GN,0 (LLA), and Integrated Diagnostics (IDHC). These companies are all part of the "diagnostics & research" industry.

Abingdon Health vs. Its Competitors

ANGLE (LON:AGL) and Abingdon Health (LON:ABDX) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their valuation, media sentiment, profitability, dividends, analyst recommendations, institutional ownership, earnings and risk.

ANGLE currently has a consensus price target of GBX 40, suggesting a potential upside of 584.93%. Given ANGLE's stronger consensus rating and higher probable upside, research analysts clearly believe ANGLE is more favorable than Abingdon Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
ANGLE
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00
Abingdon Health
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

17.5% of ANGLE shares are owned by institutional investors. Comparatively, 1.9% of Abingdon Health shares are owned by institutional investors. 2.7% of ANGLE shares are owned by company insiders. Comparatively, 10.4% of Abingdon Health shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

ANGLE has a beta of 0.22, suggesting that its stock price is 78% less volatile than the S&P 500. Comparatively, Abingdon Health has a beta of 0.13, suggesting that its stock price is 87% less volatile than the S&P 500.

Abingdon Health has a net margin of -20.72% compared to ANGLE's net margin of -890.91%. Abingdon Health's return on equity of -62.56% beat ANGLE's return on equity.

Company Net Margins Return on Equity Return on Assets
ANGLE-890.91% -76.01% -29.89%
Abingdon Health -20.72%-62.56%-17.93%

In the previous week, ANGLE had 2 more articles in the media than Abingdon Health. MarketBeat recorded 2 mentions for ANGLE and 0 mentions for Abingdon Health. ANGLE's average media sentiment score of 0.20 beat Abingdon Health's score of 0.00 indicating that ANGLE is being referred to more favorably in the media.

Company Overall Sentiment
ANGLE Neutral
Abingdon Health Neutral

Abingdon Health has higher revenue and earnings than ANGLE. Abingdon Health is trading at a lower price-to-earnings ratio than ANGLE, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
ANGLE£2.86M6.58-£21.76M-£0.05-121.16
Abingdon Health£6.82M1.60-£796.37K-£0.01-773.15

Summary

ANGLE beats Abingdon Health on 9 of the 16 factors compared between the two stocks.

Get Abingdon Health News Delivered to You Automatically

Sign up to receive the latest news and ratings for ABDX and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

ABDX vs. The Competition

MetricAbingdon HealthDiagnostics & Research IndustryMedical SectorLON Exchange
Market Cap£10.93M£54.06M£5.77B£2.57B
Dividend YieldN/A3.93%6.70%5.30%
P/E Ratio-773.151.0675.845,395.93
Price / Sales1.60494.22524.9697,029.82
Price / Cash2.2511.4225.7027.93
Price / Book7.762.6011.917.98
Net Income-£796.37K£334.07B£3.28B£5.89B
7 Day Performance-3.24%-2.57%1.11%0.63%
1 Month Performance-13.50%10.74%8.17%55.78%
1 Year Performance-41.75%10.15%67.79%197.77%

Abingdon Health Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ABDX
Abingdon Health
N/AGBX 5.64
+2.5%
N/A-43.2%£10.93M£6.82M-773.1584Gap Down
High Trading Volume
AGL
ANGLE
1.9187 of 5 stars
GBX 6.50
+8.3%
GBX 40
+515.4%
-43.8%£20.96M£2.86M-134.85650Gap Down
YGEN
Yourgene Health
N/AN/AN/AN/A£16.43M£29.67M-51.50253
PRM
Proteome Sciences
N/AGBX 3.20
+12.3%
N/A-6.5%£9.15M£4.89M-278.26240Gap Down
VRCI
Verici Dx
N/AGBX 0.50
-4.6%
N/A-92.5%£7.95M£3.34M-20.0419Gap Up
GDR
genedrive
N/AGBX 0.60
-22.6%
N/A-81.5%£4.84M£676K-27.7843Gap Down
High Trading Volume
GENI
GENinCode
N/AGBX 1.50
+7.1%
N/A-77.8%£4.02M£2.70M-59.292,300Gap Down
DMTR
Deepmatter Group
N/AN/AN/AN/A£1.33M£1.04M-0.11N/AGap Down
LLAI
LungLife AI
N/AGBX 3.50
-17.6%
N/A-73.3%£1.16M£33.87K-0.2815News Coverage
Gap Down
High Trading Volume
LLA
LLA.L,0P0001T9GN,0
N/AN/AN/AN/A£0.00N/A-25.0015Gap Down
High Trading Volume
IDHC
Integrated Diagnostics
N/AGBX 0.49
flat
N/A+35.9%£275.55M£5.72B0.276,692

Related Companies and Tools


This page (LON:ABDX) was last updated on 9/8/2025 by MarketBeat.com Staff
From Our Partners